Christine Fox

Insider Reports History

Location
Petach Tikva, Israel
Signature
/s/ Dov Bergwerk as attorney-in-fact for Christine Fox
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Christine Fox:

Company Role Class Num Shares Value Price $ Report Date Ownership
TEVA PHARMACEUTICAL INDUSTRIES LTD EVP, U.S. Commercial Ordinary Shares 75,010 $2,435,162 $32.46 04 Mar 2026 Direct
TEVA PHARMACEUTICAL INDUSTRIES LTD EVP, U.S. Commercial Restricted Share Units 50,643 04 Mar 2026 Direct

Insider Reports Filed by Christine Fox

Symbol Company Period Transactions Value $ Form Type Role Filing Time
TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD 04 Mar 2026 4 -$295,362 4 EVP, U.S. Commercial 06 Mar 2026, 16:05
TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD 20 Nov 2025 3 -$699,523 4 EVP, Head of U.S. Commercial 24 Nov 2025, 16:03
TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD 14 Nov 2025 1 -$753,321 4 EVP, Head of U.S. Commercial 18 Nov 2025, 16:01
TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD 05 Mar 2025 1 $0 4 EVP, Head of U.S. Commercial 07 Mar 2025, 16:25
TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD 04 Mar 2025 4 -$97,639 4 EVP, Head of U.S. Commercial 06 Mar 2025, 16:19
TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD 20 Nov 2024 3 -$327,085 4 EVP, Head of U.S. Commercial 21 Nov 2024, 16:04
TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD 04 Mar 2024 1 $0 4 EVP, Head of U.S. Commercial 05 Mar 2024, 16:35
TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD 20 Nov 2023 1 $0 4 EVP, Head of U.S. Commercial 22 Nov 2023, 07:18
TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD 20 Nov 2023 0 $0 3 EVP, Head of U.S. Commercial 22 Nov 2023, 07:17